Argenica Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 7, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	87	97	37	37	15	-
Market Cap Growth	59.59%	162.45%	-1.32%	155.40%	-	-
Enterprise Value	72	88	29	32	13	-
Last Close Price	0.68	0.78	0.38	0.43	0.20	-
PS Ratio	28.36	37.26	21.08	144.26	49.43	-
PB Ratio	6.62	6.94	4.81	4.50	2.14	-
P/TBV Ratio	6.62	6.94	4.81	4.50	2.14	-
EV/Sales Ratio	23.47	34.02	16.43	123.78	45.30	-
Asset Turnover	0.26	0.20	0.19	0.03	0.08	-
Quick Ratio	6.92	6.71	5.06	12.21	16.97	1.05
Current Ratio	6.95	6.75	5.09	12.29	17.08	1.05
Return on Equity (ROE)	-53.13%	-50.70%	-60.29%	-53.99%	-29.99%	-
Return on Assets (ROA)	-29.50%	-27.35%	-32.79%	-31.35%	-16.82%	-
Return on Capital (ROIC)	-35.82%	-32.79%	-38.15%	-33.76%	-18.75%	-
Earnings Yield	-6.02%	-5.66%	-13.05%	-10.95%	-7.03%	-
Buyback Yield / Dilution	-46.14%	-40.29%	-	-108.80%	-112.54%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.